the aid library

Filter

13473

Download

View PDF

Debunking tobacco industry misinformation

Word Health Organization WHO (2025) C_WHO

Tobacco mythbusters: tools for debunking common myths promoted by the tobacco industry

Download

View PDF

Aide-mémoire for national strategies for the safe management of health care waste

World Health Organization (2001) C_WHO

Download

View PDF

Rwanda: Tuberculosis Facts Info

Rwanda Biomedical Center - Institute of HIVAIDS, Disease prevention & Control (IHDPC), TB & Other Respiratory Communicable Diseases Division (2015) C2

Fact sheet on Tuberculosis in Rwanda

Download

View PDF

Lao People’s Democratic Republic-WHO Country Cooperation Strategy 2024–2028

World Health Organization WHO (2023) C_WHO

This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector development plans and the Health Sector Reform Strategy ... 2021–2030 to attain the Sustainable Development Goals (SDGs) by 2030. The Lao People’s Democratic Republic experienced substantial economic growth in the 30 years prior to the coronavirus disease (COVID-19) pandemic, contributing to reduced poverty and significant progress toward the SDGs. However, the COVID-19 pandemic brought this development to a halt. It was anticipated that the COVID-19 recovery and the tremendous population growth in recent years would provide opportunities for a shift toward more sustainable and inclusive development in the years ahead. In 2023, however, the contrary was the case. Rural residents, including many ethnic minorities, continued to face marginalization because of limited access to education, health care and economic opportunities. Despite the challenges of COVID-19 and other disease outbreaks, the country has made significant improvements in health. Nonetheless, progress has been uneven and not everyone has benefited from these achievements. In the mountainous region, many people lack access to quality health care because of the unequal distribution of well-trained health-care workers. Preventable deaths due to poor-quality health care for children and newborns, infants and mothers remain a concern, as do communicable diseases such as sexually transmitted infections and tuberculosis. The increasing burden of noncommunicable diseases and the health impact of worsening climate change further heighten the need for strengthened and resilient health systems, which are at risk due to an underfunded health sector and weak economy. This CCS aims to address remaining and future challenges as well as health needs while creating an impact that is sustainable. It identifies three strategic priorities and nine deliverables (Table 1) to support the attainment of the national vision of Health for all by all, as articulated in the 9th Health Sector Development Plan 2021–2025. It contributes to the country’s goals to achieve universal health coverage, graduate from least developed country status by 2026 and attain SDGs by 2030. more

Download

View PDF

Limpieza y desinfección de las superficies del entorno inmediato en el marco de la COVID-19
recommended

Organización Mundial de la Salud OMS (2020) C_WHO

El propósito de este documento es proporcionar orientación sobre la limpieza y desinfección de las superficies ambientales en el contexto de COVID-19. Esta orientación está destinada a los profesionales de la salud, los profesionales de la salud pública y las autoridades sanitarias que están ... more

Download

View PDF

Prevención de las infecciones nosocomiales

Organización Mundial de la Salud (2002)

Download

View PDF

Уборка и дезинфекция помещений и поверхностей в контексте COVID-19

World Health Organization WHO (2020) C_WHO

Цель настоящего документа - дать указания по очистке и дезинфекции поверхностей окружающей среды в контексте КОВИД-19. Настоящее руководство предназначено для раб� ... more

Download

View PDF

International health regulations (‎2005)‎: state party self-assessment annual reporting tool, 2nd ed

World Health Organization WHO (2022) C_WHO

Second edition. AVailable in English, French, Spanish, Russian, Chinese and Portuguese

External Link

WASH and Health working together: a ‘how-to’ guide for neglected tropical disease programmes
recommended

World Health Organization World Health Organization WHO (2023) C_WHO

2nd edition. This toolkit provides step-by-step guidance to NTD programme managers and partners on how to engage and work collaboratively with the WASH community to improve delivery of water, sanitation and hygiene services to underserved population affected by many neglected tropical diseases. The ... more

External Link

Medical Isolation Facilities in Outbreak Responses
recommended

Oxfam (2018) C1

This technical briefing paper details the construction and setup of medical isolation facilities in support of infectious disease outbreak responses.

Download

View PDF

Fit for women? Safe and decent PPE for women health and care workers

Women for Global Health WGH (2021) CC

One of the many gender inequities in the health and care workforce that COVID-19 has exposed is around the fit and design of Personal Protective Equipment (PPE). The rapid onset and scale of COVID-19 led to shortages of PPE in most countries, causing preventable infection and mortality among healthc ... more

Download

View PDF

Current Profile of New HIV Infections Among Adults in Northern Benin in 2016

Cossi Angelo Attinsounon, Comlan Albert Dovonou, René Kèkè, Cossi Adébayo Alassani, Kouessi Anthelme Agbodandé, Finagnon Armand Wanvoegbe, Angèle Kouanou-Azon, Djimon Marcel Zannou Science Publishing Group (2017) C2

Objective: The study aimed to describe the current epidemiological, clinical and immunological profile of newly detected HIV - positive patients in Northern Benin by 2016. Methods: It was a prospective study conducted from May 2 to October 31, 2016 on three main sites of care of people living with ... more

Download

View PDF

Utilisation de la ventilation naturelle pour lutter contre les infections en milieu de soins

J. Atkinson, Y. Chartier, C.L.Pessoa-Silva, et.al Organisation Mondiale de la Santé (2009)

Download

View PDF

WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings
recommended

World Health Organization (2016) C_WHO

Download

View PDF

Guidelines for Management of ST-Elevated Myocardial Infarction

Directorate General of Health Services Ministry of Health & Family Welfare Government of India (2022) CC

Myocardial infarctions are generally clinically classified into ST elevation MI (STEMI) and non-ST elevation MI (NSTEMI), based on changes in ECG. When blood flow to a part of the heart stops or the heart is injured and fails to receive enough oxygen required for its adequate functioning the conditi ... more

Download

View PDF

Democratic Republic of Timor-Leste Ministry of Health - Comprehensive TB Guidelines for National Tuberculosis Program, V Edition

Government of Timor-Leste; World Health Organization (2023) CC

The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death. The salient observations are as follows: In 2018, 487 (12.5%) of the ... more

Download

View PDF

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for ... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download

View PDF

Краткое руководство по туберкулезу для работников первичной медикосанитарной помощи

Ниша Ахамед, Елена Юрасова, Ричард Залексис World Health Organization, National Tuberculosis Center (2004) C_WHO

Руководство для медицинского персонала Brief tuberculosis manual for primary health care workers

Download

View PDF

Tool for the assessment of injection safety

World Health Organization (2001) C_WHO

Download

View PDF

Précautions standard pour contrôler les infections à l'hôpital

Organisation Mondiale de la Santé OMS (1998)

Limpieza y desinfección de las superficies del entorno inmediato en el marco de la COVID-19 recommended

WASH and Health working together: a ‘how-to’ guide for neglected tropical disease programmes recommended

Medical Isolation Facilities in Outbreak Responses recommended

WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings recommended

Limpieza y desinfección de las superficies del entorno inmediato en el marco de la COVID-19
recommended

WASH and Health working together: a ‘how-to’ guide for neglected tropical disease programmes
recommended

Medical Isolation Facilities in Outbreak Responses
recommended

WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings
recommended